Home > Specialists > Hematology > Dr. Jun Shi (石军)
Specialty & Clinical Focus:
Shanghai-based hematologist and Director of the Department of Hematology at Shanghai Ninth People’s Hospital, with more than two decades of experience in leukemia, lymphoma, multiple myeloma, myelodysplastic syndromes, anemia and other hematological disorders.
Professional Title & Qualifications:
Chief Physician
Doctoral Supervisor
Hospital & Department：
Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine – Department of Hematology
(address: No. 639 Zhizaoju Road, Huangpu District, Shanghai, 200011)
Dr. Jun Shi (石军) - Hematologist
Personal Biography
Dr. Jun Shi is Chief Physician and Director of the Department of Hematology at Shanghai Ninth People’s Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. She holds a doctorate and serves as a doctoral supervisor.
With more than two decades of experience in clinical hematology, medical teaching and scientific research, Dr. Shi focuses on the diagnosis and management of leukemia, lymphoma, multiple myeloma, myelodysplastic syndromes, anemia and other hematological disorders. Her academic work includes leading and participating in national-level research projects, publishing in peer-reviewed journals, contributing to professional medical books and holding patents for medical innovations.
Why Consult Dr. Jun Shi for Hematological Care in China
Clinical Leadership in Complex Hematology
Dr. Jun Shi brings more than two decades of experience in clinical hematology, medical teaching and scientific research. As Chief Physician and Director of the Department of Hematology at Shanghai Ninth People’s Hospital, she focuses on the diagnosis and management of leukemia, lymphoma, multiple myeloma, myelodysplastic syndromes, anemia and other blood disorders. For international patients considering care in China, this combination of department-level clinical leadership and focused hematology experience can be particularly valuable when complex records and priority questions require specialist review before travel.
Research-Informed Pre-Travel Review
Dr. Shi has led and participated in national-level research projects, including projects funded by the National Natural Science Foundation of China, and has contributed to peer-reviewed publications, professional medical books and medical innovation patents. For a remote specialist review, organized laboratory findings, bone marrow reports, imaging, previous treatment records and priority questions provide the context needed for Dr. Shi to give her specialist opinion, recommendations and responses regarding potential clinical pathways. This can help patients prepare a more focused next step, whether additional records or an in-person evaluation in Shanghai is considered.
Pre-Travel Case Review & Specialist Liaison
Travelling internationally for specialized hematology care requires substantial planning. Beginning with a pre-travel remote specialist review can help you understand which records are required, address your priority questions and clarify the next clinical and logistical steps before arranging travel to Shanghai.
MedBridgeNZ will organize your laboratory results, bone marrow reports, diagnostic imaging, treatment history and question list; coordinate translation where needed; and complete client-authorized document transfer and appointment communication with the relevant hospital team. Once the remote review arrangement is confirmed, Dr. Shi will review the submitted records, provide her specialist opinion and recommendations, and respond to your questions.
If you choose to proceed with an in-person pathway, MedBridgeNZ can coordinate appointment communication, medical invitation or visa-document support, travel and accommodation planning, and non-clinical bilingual administrative support in Shanghai.
Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.
Secure a Remote Case Review with
Dr. Jun Shi
Areas of Expertise
Diagnosis and treatment of leukemia
Lymphoma
Multiple myeloma
Myelodysplastic syndromes
Anemia and other hematological disorders
Verified Client Satisfaction Metrics
⭐⭐⭐⭐⭐ 5.0/5.0 Overall Rating
* Treatment Pathway Satisfaction:
5.0/5.0
* Communication & Professionalism:
5.0/5.0
* High demand: Chosen online for specialist liaison and case reviews by over:
2,000 clients
(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)
Work Experience
Director and Chief Physician, Department of Hematology, Shanghai Ninth People's Hospital
Engaged in clinical work, teaching, and research in hematology for over two decades
Education & Training
Awards & Honors
Academic & Professional Memberships
Member, Chinese Medical Association
Committee Member, Hematology Branch of the Shanghai Medical Association
Member, China Anti-Cancer Association
Research & Publications
Led and participated in several national-level research projects, including projects funded by the National Natural Science Foundation of China (NSFC)
Published numerous academic papers in domestic and international peer-reviewed journals
Authored chapters in multiple professional medical books
Awarded patents for medical innovations
Selected Peer-Reviewed Publications
Below is a selection of Dr. Shi's peer-reviewed hematology research:
A CD36-dependent non-canonical lipid metabolism program promotes immune escape and resistance to hypomethylating agent therapy in AML. Guo HZ, Feng RX, Zhang YJ, Yu YH, Lu W, Liu JJ, Yang SX, Zhao C, Zhang ZL, Yu SH, Jin H, Qian SX, Li JY, Zhu J, Shi J. Cell Rep Med. 2024 Jun 18;5(6):101592. doi: 10.1016/j.xcrm.2024.101592. Epub 2024 Jun 5. PMID: 38843841
miR-29c&b2 encourage extramedullary infiltration resulting in the poor prognosis of acute myeloid leukemia. Wei Y, Lu W, Yu Y, Zhai Y, Guo H, Yang S, Zhao C, Zhang Y, Liu J, Liu Y, Fei J, Shi J. Oncogene. 2021 May;40(19):3434-3448. doi: 10.1038/s41388-021-01775-9. Epub 2021 Apr 22. PMID: 33888868
Leukemia cells remodel marrow adipocytes via TRPV4-dependent lipolysis. Yang S, Lu W, Zhao C, Zhai Y, Wei Y, Liu J, Yu Y, Li Z, Shi J. Haematologica. 2020 Nov 1;105(11):2572-2583. doi: 10.3324/haematol.2019.225763. PMID: 33131246
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.
Frequently Asked Questions (FAQs)
How can I determine whether Dr. Shi’s expertise matches my blood disorder?
Dr. Shi’s clinical focus includes leukemia, lymphoma, multiple myeloma, myelodysplastic syndromes, anemia and other hematological disorders. MedBridgeNZ can organize your laboratory results, bone marrow reports, imaging, treatment history and priority questions for a pre-travel remote specialist review. Once the review arrangement is confirmed, Dr. Shi will examine the submitted records, provide her specialist opinion and recommendations, and answer your questions. This gives you a clearer basis for deciding whether further records or an in-person evaluation in Shanghai should be considered.
How can an overseas patient request an appointment with Dr. Shi?
Contact MedBridgeNZ with your diagnosis, recent reports and preferred timeframe. We will confirm the documents required by the relevant hospital office, coordinate translation and client-authorized document transfer, and submit the appointment request for communication with Dr. Shi’s department. Appointment timing depends on the hospital and specialist schedule. Once an appointment is confirmed, we can coordinate medical invitation or visa-document support, travel planning, accommodation and non-clinical bilingual administrative support for your hospital visit.
Can Dr. Shi review my medical records before I travel to China?
Yes. A remote specialist-review pathway allows Dr. Shi to review your submitted laboratory findings, bone marrow reports, imaging, treatment history and question list before you decide whether to travel. MedBridgeNZ coordinates record preparation, translation where needed, client-authorized document transfer and scheduling communication. Once the arrangement is confirmed, Dr. Shi will provide her specialist opinion and recommendations and respond to the questions included with your case. This helps you prepare for the next step without committing immediately to an in-person visit.
What support is available if an in-person evaluation in Shanghai is recommended?
If Dr. Shi recommends further in-person evaluation, MedBridgeNZ can coordinate the administrative and logistical steps for Shanghai. Support can include appointment communication with the hospital, medical invitation or visa-document coordination, travel and accommodation planning, translation coordination and non-clinical bilingual administrative support during hospital visits. We will also help organize the records and questions carried forward from the remote review so that the in-person pathway is better prepared and easier to navigate.
Flexible Ways to Connect with the Specialist
We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:
-
Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.
-
On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.
-
In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.
How MedBridgeNZ Helps You:
MedBridgeNZ is a medical concierge and logistics coordination provider for international patients exploring specialist-care pathways in China. We assist with medical-record preparation, translation coordination, client-authorized document transfer, appointment request communication, medical invitation or visa-document coordination support, travel planning, accommodation coordination and non-clinical bilingual administrative support. Our role is to make the cross-border process more organized from initial record preparation through the hospital visit. We do not provide medical advice, diagnosis or treatment. Third-party medical and travel costs remain separate unless expressly stated in writing.